HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Wednesday 22 March 2017

CEAs, systematic reviews and epidemiological models in LMICs

To help us keep on top of current research in low and middle-income countries, we are running a monthly search of research that are aligned to our core research interests.  It's a simple search strategy, with those published in February that are most aligned to our interests listed below.  The full list of articles is kept in our "Searches archive" in the right-hand column.
  • Htet KK, Liabsuetrakul T, Thein S. Cost-effectiveness of a new strategy to detect pulmonary tuberculosis in household contacts in Myanmar. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2017;21(2):181-7.
  • Coffey PS, Brown SC. Umbilical cord-care practices in low- and middle-income countries: a systematic review. BMC pregnancy and childbirth. 2017;17(1):68.
  • Shafie AA, Yeo HY, Coudeville L, Steinberg L, Gill BS, Jahis R, et al. The Potential Cost Effectiveness of Different Dengue Vaccination Programmes in Malaysia: A Value-Based Pricing Assessment Using Dynamic Transmission Mathematical Modelling. PharmacoEconomics. 2017.
  • Hansen KS, Ndyomugyenyi R, Magnussen P, Lal S, Clarke SE. Cost-effectiveness analysis of malaria rapid diagnostic tests for appropriate treatment of malaria at the community level in Uganda. Health policy and planning. 2017.
  • Njoroge M, Zurovac D, Ogara EA, Chuma J, Kirigia D. Assessing the feasibility of eHealth and mHealth: a systematic review and analysis of initiatives implemented in Kenya. BMC research notes. 2017;10(1):90.
  • Lu S, Ye M, Ding L, Tan F, Fu J, Wu B. Cost-effectiveness of gefitinib, icotinib, and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China. Oncotarget. 2017;8(6):9996-10006.
  • Yan X, Gu X, Xu Z, Lin H, Wu B. Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in China. Advances in therapy. 2017;34(2):466-80.
Image: research by Samuel Huron